ArticleWhy Patients are "Failing" on Ozempic
There’s a growing narrative that medications like Ozempic are a “quick fix.”
The truth is, they’re not.
In fact, despite the surge in use, some patients don’t achieve the results they expect. Estimates suggest that about 1 in 8 Americans have used a GLP-1 medication. At the same time, real-world data shows that 50–75% of patients stop use within a year.
From a clinical perspective, failure on Ozempic (and other GLP-1 receptor agonists) is rarely about the medication itself.
It’s about everything around it. Let’s take a look at some factors that greatly influence results.
Lifestyle Still Matters, and does more work than people think
Most people assume the medication will do all the heavy lifting; that they can just sit back and watch the weight fall off.
This is just not the case.
Common patterns I see:
Inadequate protein intake
Poor hydration
No or inadequate resistance training
Poor sleep and chronic stress
Research consistently shows that:
Higher protein intake during weight loss helps preserve lean muscle mass and improves fat loss outcomes
Resistance training has been shown to preserve metabolic rate and lean mass during caloric restriction
Poor sleep is associated with reduced fat loss and increased hunger signals
Chronic stress raises cortisol, which is linked to increased appetite and increased central (abdominal) fat
Though one of the main actions of GLP-1 medications is to reduce appetite, they don’t automatically create a metabolically healthy body.
If patients merely eat less, but not better, they lose weight but not in a way that supports long-term health.
The Body Pushes Back
One of the most overlooked realities is that “your body will push back”.
There’s strong evidence that with weight loss:
Leptin levels decrease (decreased satiety or fullness) and Ghrelin levels increase, driving hunger
Energy expenditure may decrease to preserve energy
The body becomes more efficient, burning fewer calories
Some patients also have underlying factors that make things harder:
Hypothyroidism
Significant insulin resistance
Variable response to GLP-1 medications (what we clinically see as reduced sensitivity suggested by new research)
So when weight loss slows, it’s not necessarily a simple “The medications don’t work” situation. Our bodies may just be doing what they were designed to do.
Treatment Is Often Incomplete or Inconsistent
In clinical trials, these medications work very well.
In real life, results may be far more variable.
As previously noted, studies and real-world analyses show high discontinuation rates. Estimates place this at up to 50–75% within the first year. A huge part of that comes down to how treatment is managed.
I often see:
Doses that are never properly escalated
Inconsistent use week to week
Patients stopping early due to side effects without support
GLP-1 medications are not “take it and see.” They require structured follow-up and proper titration to actually work as intended. Patients need a system that supports them.
The Real-World Barriers No One Talks About
Even highly motivated patients struggle with:
Cost of medication
Limited access to consistent care
Unrealistic expectations about speed and magnitude of results
Clinical trials show meaningful weight loss over time, not in a few weeks. When patients expect rapid, linear results, normal plateaus feel like failure. When expectations don’t match reality, patients assume failure and discontinue therapy.
What I’ve learned
The patients who do well are not the ones who rely on the medication alone.
They:
Prioritize protein
Strength train consistently
Treat sleep like it matters (because it does)
Stay on therapy long enough, at the right dose
Have a plan beyond just “losing weight”
The World Health Organization, in December 2025, released its guidelines for the use of GLP-1 receptor agonists in Weight Management. Notably, the recommendations include long-term use, combined with lifestyle changes.
Final thought
Ozempic and other GLP-1 receptor agonists work!
But they work best inside a system that supports the patient. When that system is missing, patients don’t fail because they lack discipline. They fail because they were given a tool without the structure needed to use it properly.
If we want better outcomes, we have to treat more than weight. We have to treat the whole metabolic system, and the human being living inside it.
Read about how these medications should be used here at www.lukariagroup.com
Posted on: Jun 1, 2026 • kadriaf@lukariagroup.com 
Svelteby LuKaria
